Atossa Genetics

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$0
$0
$0
$0
Gross Profit
-4
-4
-4
-4
EBITDA
-8,419
-6,714
-7,147
-6,381
EBIT
-8,423
-6,718
-7,151
-6,385
Net Income
-8,423
-6,718
-6,347
-7,230
Net Change In Cash
0
0
0
0
Free Cash Flow
-7,259
-5,968
-7,051
-4,760
Cash
57,857
65,116
71,084
74,766
Basic Shares
129,170
129,170
126,621
125,772

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-17
-23
-8
-23
EBITDA
-25,487
-31,354
-27,683
-20,498
EBIT
-25,504
-31,377
-27,691
-20,521
Net Income
-25,504
-30,094
-26,229
-20,606
Net Change In Cash
0
0
0
0
Cost of Revenue
-25,487
96,823
Free Cash Flow
-21,049
-20
-20,787
-16,481
Cash
71,084
88,460
110,890
136,377
Basic Shares
125,859
126,081
126,624
116,950

Earnings Calls

Quarter EPS
2025-09-30
$0
2025-06-30
-$0.07
2025-03-31
-$0.05
2024-12-31
-$0.05